(2022). Transparency of high-dimensional propensity score analyses: guidance for diagnostics and reporting. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5412.
(2020). Implementing high-dimensional propensity score principles to improve confounder adjustment in UK electronic health records. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5121.
(2021). Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study. Lancet Digit Health. http://doi.org/10.1016/s2589-7500(21)00017-0.